# FDA 483 - Erika P. Hamilton, MD - May 12, 2017

Source: https://www.globalkeysolutions.net/records/483/erika-p-hamilton-md/c5956ee2-b276-49d0-9551-ee4bd62ad628

> FDA 483 for Erika P. Hamilton, MD on May 12, 2017. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Erika P. Hamilton, MD
- Inspection Date: 2017-05-12
- Product Type: drugs
- Office Name: New Orleans District Office
- Summary: An FDA inspection of Erika P. Hamilton, MD in Nashville, TN, a clinical investigator, revealed that an investigation was not conducted in accordance with the investigational plan. Specifically, four out of 17 enrolled subjects received incorrect dosing diaries, leading to potential deviations in drug administration instructions. This indicates a significant issue with protocol adherence and subject management during the clinical trial.

## Related Officers

- [issuing_officer](https://www.globalkeysolutions.net/people/laura-l-staples/fe59bc9c-b439-4dd8-8c8a-5fac6f7733f8)

Company: https://www.globalkeysolutions.net/companies/erika-p-hamilton-md/4a6f68d8-371b-454e-82ba-2fa7dc493c94

Office: https://www.globalkeysolutions.net/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea